share_log

Regeneron Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer

SEC announcement ·  Aug 9, 2023 16:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more